These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1737670)

  • 41. Ajmaline in WPW syndrome: an electrophysiologic study.
    Khalilullah M; Sathyamurthy I; Singhal NK
    Am Heart J; 1980 Jun; 99(6):766-71. PubMed ID: 7377098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ajmaline on rate-dependent atrioventricular node properties. Potential role in experimental atrioventricular re-entrant tachycardia.
    Nayebpour M; Naseri M; Khori V
    Eur J Pharmacol; 2001 Jan; 412(1):77-89. PubMed ID: 11166739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adenosine triphosphate and supraventricular tachycardia].
    Pella J
    Vnitr Lek; 1994 Nov; 40(11):702-6. PubMed ID: 7810092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents.
    Tisdale JE; Patel R; Webb CR; Borzak S; Zarowitz BJ
    Prog Cardiovasc Dis; 1995; 38(2):167-80. PubMed ID: 7568905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
    DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
    Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
    Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy.
    Paul T; Bertram H; Bökenkamp R; Hausdorf G
    Paediatr Drugs; 2000; 2(3):171-81. PubMed ID: 10937468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A shared pathway in atrioventricular nodal reentrant tachycardia and atrial flutter: implications for pathophysiology and therapy.
    Interian A; Cox MM; Jimenez RA; Duran A; Levin E; Garcia O; Cooper DK; Castellanos A; Myerburg RJ
    Am J Cardiol; 1993 Feb; 71(4):297-303. PubMed ID: 8427171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
    Rowland E; McKenna WJ; Krikler DM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pirmenol in the termination of paroxysmal supraventricular tachycardia.
    Toivonen LK; Nieminen MS; Manninen V; Frick H
    Am J Cardiol; 1987 Jun; 59(16):35H-38H. PubMed ID: 3591712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catheter ablation of supraventricular arrhythmias and atrial fibrillation.
    Shapira AR
    Am Fam Physician; 2009 Nov; 80(10):1089-94. PubMed ID: 19904893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation.
    Lesh MD; Van Hare GF; Fitzpatrick AP; Griffin JC; Chu E
    J Electrocardiol; 1993; 26 Suppl():194-203. PubMed ID: 8189124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective placebo controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing.
    Lemery R; Pecarskie A; Bernick J; Williams K; Wells GA
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):1-6. PubMed ID: 25081280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias.
    Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P
    Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrograde dual atrioventricular nodal pathway in patients with atrioventricular reciprocating tachycardia using concealed accessory pathways.
    Hluchý J; Milovský V
    Int J Cardiol; 1990 Jan; 26(1):67-74. PubMed ID: 2298519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.